Eastman Chemical CO Form 4 insider transactions

Eastman Chemical's Controller and CAO, Michelle Renee Stewart, acquired 3,309 shares of common stock as performance shares for the 2023-2025 period.

Eastman Chemical's SVP, Julie A. McAlindon, acquired 7,280 shares of common stock as performance-based compensation for the 2023-2025 period.

Eastman Chemical Co.'s SVP & Chief Manufacturing Officer, Michelle H. Caveness, acquired 1,937 shares of common stock as performance shares.

Eastman Chemical's EVP, Brian Travis Smith, acquired 10,589 shares of common stock as part of performance share determination.

Adrian James Holt, SVP and Chief HR Officer at Eastman Chemical Co., received 2,297 shares of common stock as performance-based compensation.

Eastman Chemical CEO Mark J. Costa exercised stock options, acquiring shares and simultaneously disposing of a portion for tax and exercise costs.

Eastman Chemical's EVP and CFO, William Thomas McLain Jr., exercised stock options, resulting in a net increase of 377 shares in his direct beneficial ownership.

Eastman Chemical's EVP of Technology Projects, Stephen G. Crawford, was granted 34,193 restricted stock units vesting in February 2027.

Eastman Chemical Director Damon J. Audia increased his beneficial ownership of phantom stock units through deferred compensation.

Eastman Chemical Co. Director Renee J. Hornbaker acquired 487 phantom stock units through an automatic deferral of annual retainer fees.

Eastman Chemical Company Director Linnie M. Haynesworth acquired 487 phantom stock units through an automatic deferral of annual retainer fees.

Eastman Chemical Co. Director Eric L. Butler acquired 487 phantom stock units through an automatic deferral of annual retainer fees.

Eastman Chemical Company director Julie Fasone Holder acquired 487 phantom stock units through a deferred compensation plan, increasing her total beneficial ownership to 14,377 units.

Director James J. O'Brien acquired 487 phantom stock units of Eastman Chemical through a deferral of director's fees.

Eastman Chemical Director Donald W. Slager deferred a portion of his annual retainer fees into 487 phantom stock units, increasing his total beneficial ownership to 1,267 units.

Eastman Chemical Co. Director Brett D. Begemann increased his beneficial ownership of phantom stock units through voluntary and automatic fee deferrals.

Eastman Chemical Director Kim Ann Mink increased her beneficial ownership of phantom stock units through an automatic deferral of fees.

Eastman Chemical Co. Director Humberto P. Alfonso increased his beneficial ownership of phantom stock units through deferral of director fees.

Eastman Chemical's SVP & Chief Manufacturing Officer, Michelle H. Caveness, reported the vesting of restricted stock units and subsequent tax withholding.

Eastman Chemical's SVP, Chief HR Officer, Adrian James Holt, acquired 2,200 phantom stock units under an executive deferred compensation plan.

Brian Travis Smith, EVP at Eastman Chemical Co, reports purchasing 1,750 shares of common stock at $68.34 per share.

Eastman Chemical Co. Director James J. O'Brien reported a planned acquisition of 1,450 shares of common stock at $68.811 per share, effective August 27, 2025.

Eastman Chemical Co. Director Kim Ann Mink purchased 1,450 shares of common stock at $69.3799 per share, increasing her direct beneficial ownership to 2,840 shares.

Eastman Chemical Co. Director Julie Fasone Holder acquired 1,453 shares of common stock at $68.80 per share through a pre-arranged trading plan.

An Eastman Chemical Co. director acquired 3,000 shares of common stock at $68.6525 per share, signaling confidence in the company.

Eastman Chemical Co. Director Brett D. Begemann acquired 1,500 shares of common stock in a pre-planned transaction.

Eastman Chemical Director Damon Audia reported a planned purchase of 1,465 shares of common stock at $68.585 per share.

Eastman Chemical's SVP, Julie A. McAlindon, has filed a Form 4 indicating a pre-planned purchase of 2,000 shares of common stock.

Eastman Chemical's EVP & CCO, Brad A. Lich, purchased 3,280 shares of common stock at $68.49 per share, effective August 27, 2025, under a 10b5-1 plan.

Eastman Chemical's EVP and CFO, William Thomas McLain Jr., has filed a Form 4 indicating a planned purchase of 3,670 shares of common stock on August 27, 2025.